Cullinan Therapeutics, Inc (CGEM) insider trading
Every open-market stock purchase and sale by Cullinan Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $13.3M over the last 12 months (3 buys).
- Insiders sold $1.6M over the last 12 months (21 sales).
- Last insider buy: Lynx1 Capital Management LP (10% owner), $1.4M, 11 months ago.
Last 12 months: insiders bought $13.3M (3 buys) and sold $1.6M (21 sales). Last close $13.51 on Jun 4, 2026.
Recent CGEM insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 16, 2026 | David D. Meek (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Anthony Rosenberg (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Andrew R Allen (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Mittie Doyle (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Mary Thistle (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Stephen W Webster (Insider) | Bought (not open market) | — |
| May 5, 2026 | Jennifer Michaelson (C-suite exec) | Sold | $114K |
| May 5, 2026 | Jennifer Michaelson (C-suite exec) | Sold | $3.1K |
| May 5, 2026 | Jennifer Michaelson (C-suite exec) | Bought (not open market) | — |
| Mar 5, 2026 | Jennifer Michaelson (C-suite exec) | Sold | $125K |
| Mar 5, 2026 | Jennifer Michaelson (C-suite exec) | Bought (not open market) | — |
| Feb 25, 2026 | Jennifer Michaelson (C-suite exec) | Sold | $25.2K |
| Feb 24, 2026 | Nadim Ahmed (CEO) | Sold | $196K |
| Feb 24, 2026 | Jeffrey Alan Jones (C-suite exec) | Sold | $66.3K |
| Feb 24, 2026 | Jennifer Michaelson (C-suite exec) | Sold | $52.1K |
| Feb 24, 2026 | Jacquelyn L Sumer (C-suite exec) | Sold | $52.1K |
| Feb 23, 2026 | Jennifer Michaelson (C-suite exec) | Sold | $24.5K |
| Feb 20, 2026 | Nadim Ahmed (CEO) | Sold | $223K |
| Feb 20, 2026 | Jennifer Michaelson (C-suite exec) | Sold | $114K |
| Feb 20, 2026 | Jeffrey Alan Jones (C-suite exec) | Sold | $67.9K |
| Feb 20, 2026 | Mary Kay Fenton (CFO) | Sold | $59.9K |
| Feb 20, 2026 | Jennifer Michaelson (C-suite exec) | Sold | $51K |
| Feb 20, 2026 | Jacquelyn L Sumer (C-suite exec) | Sold | $51K |
| Feb 20, 2026 | Jennifer Michaelson (C-suite exec) | Bought (not open market) | — |
| Feb 18, 2026 | Corrine Savill (C-suite exec) | Bought (not open market) | — |
Who's trading CGEM
- Stephen W Webster, Insider: other filings, last Jun 16, 2026
- Andrew R Allen, Insider: other filings, last Jun 16, 2026
- Mittie Doyle, Insider: other filings, last Jun 16, 2026
- David D. Meek, Insider: other filings, last Jun 16, 2026
- Anthony Rosenberg, Insider: other filings, last Jun 16, 2026
- Mary Thistle, Insider: other filings, last Jun 16, 2026
- Jennifer Michaelson, C-suite exec: sold $693K (15 sales), last May 5, 2026
- Jacquelyn L Sumer, C-suite exec: sold $137K (3 sales), last Feb 24, 2026
- Jeffrey Alan Jones, C-suite exec: sold $179K (3 sales), last Feb 24, 2026
- Nadim Ahmed, CEO: sold $518K (3 sales), last Feb 24, 2026
- Mary Kay Fenton, CFO: sold $59.9K (1 sale), last Feb 20, 2026
- Corrine Savill, C-suite exec: other filings, last Feb 18, 2026
- Lynx1 Capital Management LP, 10% owner: bought $13.3M (8 buys), last Oct 28, 2025
Get free alerts when an insider at Cullinan Therapeutics, Inc files a new trade →